Table 1 Participants’ demographic, clinical and MRI parameters and their statistical analysis

Age (IQR)

67.5 (60–73)

68 (59–76)

0.98

Body surface area (IQR)

1.9 (1.6–2)

1.9 (1.8–2)

0.28

SBP, mmHg (IQR)

116 (110–130)

130 (120–145)

0.009

DBP, mmHg (IQR)

70 (70–80)

80 (70–88)

0.14

Males (%)

61.9%

66.7%

0.2

Maximum LV wall thickness, mm (IQR)

15 (12–18)

16 (13–17)

0.9

LV mass/BSA, g/m² (IQR)

77.5 (59–94)

78.3 (59.3–97.8)

0.8

LV EDV, ml (IQR)

144.5 (107–170)

75.4 (57.3–100.1)

< 0.001

LV ESV, ml (IQR)

56.5 (31–74)

29 (14.8–43.4)

0.001

LV SV, ml (IQR)

83 (67–95)

46.6 (39.8–57.3)

0.001

LV CO/BSA, ml/m² (IQR)

3.2 (0.7)

3.2 (1.3)

0.6

LVEF, %

61 (55–71)

65 (54–78)

0.4

T1 spleen, ms (IQR)

1392.5 (1346–1455)

1391 (1325–1445)

0.9

T2 mapping Spleen, ms (IQR)

80 (59–92)

79.5 (71.4–91.5)

0.8

ECV spleen %, (IQR)

47 (32–60)

31 (29–34)

< 0.001

STIR ratio spleen, (IQR)

1.7 (1.4–2.5)

2.7 (2.3–3.5)

< 0.001